Genetic variants of MnSOD and GPX1 and susceptibility to bladder cancer in a Turkish population

Medical Oncology

Volumn 29, Issue 3, 2012, Pages 1928-1934

  Kucukgergin, Canan ^a   Sanli, Oner ^a   Amasyali, Akin S ^b   Tefik, Tzevat ^a   Seckin, Sule ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b ISTANBUL TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

Bladder cancer; Glutathione peroxidase 1; Manganese superoxide dismutase; Polymerase chain reaction restriction fragment length polymerase analysis; Single nucleotide polymorphism; Turkish population

Indexed keywords

ALANINE; GLUTATHIONE PEROXIDASE 1; LEUCINE; MANGANESE SUPEROXIDE DISMUTASE; PROLINE; VALINE;

ADULT; ARTICLE; BLADDER CANCER; CANCER INVASION; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; TURKEY (REPUBLIC);

CARCINOMA, TRANSITIONAL CELL; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLUTATHIONE PEROXIDASE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SUPEROXIDE DISMUTASE; TURKEY; URINARY BLADDER NEOPLASMS;

EID: 84872768945     PISSN: 13570560     EISSN: 1559131X     Source Type: Journal    
DOI: 10.1007/s12032-011-0057-z     Document Type: Article

References (44)

1. Lamm DL, Griffith JG. Intravesical therapy: does it affect the natural history of superficial bladder cancer? Semin Urol. 1992;10:39-44.
2. MacVicar AD. Bladder cancer staging. BJU Int. 2000;86:111-22.
3. Yi{dotless}lmaz HH, et al. Cancer trends and incidence and mortality patterns in Turkey. Jpn J Clin Oncol. 2011;4:10-6.
4. Marcus PM, et al. Cigarette smoking, N-acetyltransferase 2 acetylation status, and bladder cancer risk: a case-series metaanalysis of a gene-environment interaction. Cancer Epidemiol Biomark Prev. 2000;9:461-7.
5. Zeegers MP, Kellen E, Buntinx F, Van den Brandt PA. The association between smoking, beverage consumption, diet and bladder cancer: a systematic literature review. World J Urol. 2004;21:392-401.
6. Hartge P, et al. Changing cigarette habits and bladder cancer risk: a case-control study. J Natl Cancer Inst. 1987;78:1119-25.
7. Frederiks WM, Bosch KS, Hoeben KA, Van Marle J, Langbein S. Renal cell carcinoma and oxidative stress: the lack of peroxisomes. Acta Histochem. 2010;112:364-71.
8. Pryor WA. Cigarette smoke radicals and the role of free radicals in chemical carcinogenicity. Environ Health Perspect. 1997;105: 875-82.
9. Brown NS, Bicknell R. Hypoxia and oxidative stress in breast cancer. Oxidative stress: its effects on the growth, metastatic potential and response to therapy of breast cancer. Breast Cancer Res. 2001;3:323-7.
10. Wallace DC. Mitochondrial diseases in man and mouse. Science. 1999;283:1482-8.
11. Bandy B, Davison AJ. Mitochondrial mutations may increase oxidative stress: implications for carcinogenesis and aging? Free Radic Biol Med. 1990;8:523-39.
12. Arthur JR. The glutathione peroxidases. Cell Mol Life Sci. 2000;57:1825-35.
13. Shimoda-Matsubayashi S, et al. Structural dimorphism in the mitochondrial targeting sequence in the human manganese superoxide dismutase gene. A predictive evidence for conformational change to influence mitochondrial transport and a study of allelic association in Parkinson's disease. Biochem Biophys Res Commun. 1996;226:561-5.
14. Sutton A, et al. The manganese superoxide dismutase Ala16Val dimorphism modulates both mitochondrial import and mRNA stability. Pharmacogenet Genomics. 2005;15:311-9.
15. Moscow JA, et al. Loss of heterozygosity of the human cytosolic glutathione peroxidase I gene in lung cancer. Carcinogenesis. 1994;15:2769-73.
16. Kaprio J. Science, medicine, and the future. Genetic epidemiology. BMJ. 2000;320:1257-9.
17. Ezzikouri S, et al. Polymorphisms in antioxidant defence genes and susceptibility to hepatocellular carcinoma in a Moroccan population. Free Radic Res. 2010;44:208-16.
18. Bica CG, et al. association of manganese superoxide dismutase gene polymorphism (Ala-9val9 and breast cancer in males and females. J Bras Patol Med Lab. 2007;43:219-25.
19. Hung RJ, et al. Genetic polymorphisms of MPO, COMT, MnSOD, NQO1, interactions with environmental exposures and bladder cancer risk. Carcinogenesis. 2004;25:973-8.
20. Wu SH, et al. Epistasis of oxidative stress-related enzyme genes on modulating the risks in oral cavity cancer. Clin Chim Acta. 2010;411:1705-10.
21. Peters U, et al. Variation in the selenoenzyme genes and risk of advanced distal colorectal adenoma. Cancer Epidemiol Biomark Prev. 2008;17:1144-54.
22. Hansen RD, et al. GPX1 Pro(198)Leu polymorphism, erythrocyte GPX activity, interaction with alcohol consumption and smoking, and risk of colorectal cancer. Mutat Res. 2009;664:13-9.
23. Ambrosone CB, et al. Manganese superoxide dismutase (MnSOD) genetic polymorphisms, dietary antioxidants, and risk of breast cancer. Cancer Res. 1999;59:602-6.
24. Ratnasinghe D, et al. Glutathione peroxidase codon 198 polymorphism variant increases lung cancer risk. Cancer Res. 2000;60:6381-3.
25. Poulsen HE. Oxidative DNA modifications. Exp Toxicol Pathol. 2005;57:161-9.
26. Hempel N, Ye H, Abessi B, Mian B, Melendez JA. Altered redox status accompanies progression to metastatic human bladder cancer. Free Radic Biol Med. 2009;46:42-50.
27. Badjatia N, Satyam A, Singh P, Seth A, Sharma A. Altered antioxidant status and lipid peroxidation in Indian patients with urothelial bladder carcinoma. Urol Oncol. 2010;28:360-7.
28. Khan A, Tania M, Zhang DZ, Chen HC. Antioxidant enzymes and cancer. Chin J Cancer Res. 2010;22:87-92.
29. Kucukgergin C, Sanli O, Tefik T, Aydi{dotless}n M, Ozcan F, Seckin S. Increased risk of advanced prostate cancer associated with MnSOD Ala-9-Val gene polymorphism. Mol Biol Rep. 2011. doi: 10.1007/s11033-011-0725-2.
30. Ichimura Y, et al. Increased risk of bladder cancer associated with a glutathione peroxidase 1 codon 198 variant. J Urol. 2004;172:728-32.
31. Terry PD, Umbach DM, Taylor JA. No association between SOD2 or NQO1 genotypes and risk of bladder cancer. Cancer Epidemiol Biomark Prev. 2005;14:753-4.
32. Cengiz M, Ozaydin A, Ozkilic AC, Dedekarginoglu G. The investigation of GSTT1, GSTM1 and SOD polymorphism in bladder cancer patients. Int Urol Nephrol. 2007;39:1043-8.
33. Ho JC, et al. Manganese superoxide dismutase and catalase genetic polymorphisms, activity levels, and lung cancer risk in Chinese in Hong Kong. J Thorac Oncol. 2006;1:648-53.
34. Martin RC, et al. No apparent association between genetic polymorphisms (-102 C[T) and (-9 T[C) in the human manganese superoxide dismutase gene and gastric cancer. J Surg Res. 2005;124:92-7.
35. Bermano G, Arthur JR, Hesketh JE. Role of the 3' untranslated region in the regulation of cytosolic glutathione peroxidase and phospholipid- hydroperoxide glutathione peroxidase gene expression by selenium supply. Biochem J. 1996;320:891-5.
36. Hu YJ, Diamond AM. Role of glutathione peroxidase 1 in breast cancer: loss of heterozygosity and allelic differences in the response to selenium. Cancer Res. 2003;63:3347-51.
37. Ravn-Haren G, et al. Associations between GPX1 Pro198Leu polymorphism, erythrocyte GPX activity, alcohol consumption and breast cancer risk in a prospective cohort study. Carcinogenesis. 2006;27:820-5.
38. Lee CH, et al. Effects of oxidative DNA damage and genetic polymorphism of the glutathione peroxidase 1 (GPX1) and 8-oxoguanine glycosylase 1 (hOGG1) on lung cancer. J Prev Med Public Health. 2006;39:130-4.
39. Zhao H, Liang D, Grossman HB, Wu X. Glutathione peroxidase 1 gene polymorphism and risk of recurrence in patients with superficial bladder cancer. Urology. 2005;66:769-74.
40. Abe M, et al. Single-nucleotide polymorphisms within the antioxidant defence system and associations with aggressive prostate cancer. BJU Int. 2011;107:126-34.
41. Ahn J, et al. No association between glutathione peroxidase Pro198Leu polymorphism and breast cancer risk. Cancer Epidemiol Biomark Prev. 2005;14:2459-61.
42. Raaschou-Nielsen O, et al. GPX1 Pro198Leu polymorphism, interactions with smoking and alcohol consumption, and risk for lung cancer. Cancer Lett. 2007;247:293-300.
43. Arsova-Sarafinovska Z, et al. Glutathione peroxidase 1 (GPX1) genetic polymorphism, erythrocyte GPX activity, and prostate cancer risk. Int Urol Nephrol. 2009;41:63-70.
44. Cox DG, Tamimi RM, Hunter DJ. Gene 9 Gene interaction between MnSOD and GPX-1 and breast cancer risk: a nested case-control study. BMC Cancer. 2006;6:217.